CanCatch Custom
Tumor-informed personalized ctDNA MRD approach using WES baseline profiling and patient-specific mutation tracking.
- Developer
- Burning Rock Dx
- Intended use
- Mrd
- Cancer scope
- Non-small cell lung cancer
- Specimen
- FFPE tumor tissue, Peripheral whole blood
- Molecular modality
- DNA mutation
- Current version
- CanCatch Custom current personalized MRD kit (2026)
- Evidence context
- 0 structured studies · 0 indexed performance results · 2 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.